Cogstate Limited (CGS) is a neuroscience technology company focused on enhancing brain health assessments to support the development of new medicines and enable earlier clinical insights in healthcare. Cogstate's technologies offer rapid, reliable, and highly sensitive computerised cognitive tests across various domains. These assessments are pivotal in electronic clinical outcome assessment (eCOA) solutions, replacing traditional paper-based methods with real-time data capture, thereby improving efficiency and accuracy in clinical trials and healthcare settings alike.